Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 4 Glioma 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Vision Disorders 1 Uterine Cervical Neoplasms 1 Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Pituitary Neoplasms 1 Peripheral Nervous System Diseases 1 Oligodendroglioma 1 Neuritis 1 Neoplasm Metastasis 1 Mediastinal Neoplasms 1 Lymphedema 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Esthesioneuroblastoma, Olfactory 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 61 Radiotherapy 25 Bevacizumab 21 Magnetic Resonance Spectroscopy 20 Irinotecan 18 Filgrastim 15 Carboplatin 15 Carmustine 11 Surgical Procedures, Operative 10 Etoposide 9 antineoplaston AS 2-1 8 antineoplaston A10 8 Specimen Handling 8 sargramostim 7 Radiation 7 Peripheral Blood Stem Cell Transplantation 7 Everolimus 7 Biopsy 7 Vincristine 6 Radiotherapy, Intensity-Modulated 6 Procarbazine 6 O(6)-benzylguanine 6 Erlotinib Hydrochloride 6 Topotecan 5 Melphalan 5 Magnetic Resonance Imaging 5 Lomustine 5 Genetic Therapy 5 Cyclophosphamide 5 Aminolevulinic Acid 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Astrocytoma × Diffusion Tensor Imaging × Clear all

NCT02903784 2020-09-02

BNL

University Hospital, Montpellier

Phase NA Completed

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡